The maintenance of a Buy rating and a $7 price target by a reputable analyst firm like HC Wainwright & Co. suggests a positive outlook on Armata Pharmaceuticals' stock. This endorsement could lead to increased investor confidence and potentially drive the stock price up in the short term.